Top 5 Canadian Mining Stocks This Week: Guardian Exploration Gains 94 Percent
On Thursday (September 11), Canadian Prime Minister Mark Carney revealed the first tranche of projects selected by the newly created...
Editor’s Picks: Gold Knocks Out Inflation-Adjusted High, Silver Breaks US$42
Gold’s record-setting price run continued this week, with yet another new all-time high in the books. Silver also fared well,...
Engravings on shooter’s ammo exposes Charlie Kirk assassination motive
The rifle that federal investigators believe was used in the shooting that killed conservative activist Charlie Kirk contained ammunition inscribed...
Rubio warns Brazil of US response after Bolsonaro’s conviction for plotting a coup
U.S. Secretary of State Marco Rubio said on Thursday that the U.S. would respond after former Brazilian President Jair Bolsonaro...
Secret Service agent details ‘textbook ambush,’ bizarre self-representation in Ryan Routh trial
The first day of opening statements in Ryan Routh’s federal trial ended with Judge Aileen Cannon noting the case was...
GOP triggers nuclear option in Senate to break Dem blockade of Trump nominees
After an attempt to secure a bipartisan deal failed, Senate Republicans went nuclear for the fourth time in the Senate’s...
Top conservative speakers vow they ‘will not be silenced’ after Charlie Kirk’s assassination
After the assassination of conservative commentator Charlie Kirk sent shockwaves through the political landscape this week, Fox News Digital spoke...
Karine Jean-Pierre arrives for House Oversight grilling in Biden autopen probe
Former White House press secretary Karine Jean-Pierre is appearing before the House Oversight Committee on Friday for a high-profile interview...
Providence Gold Mines Inc. Announces Financing Update on the La Dama de Oro Gold Property
(TheNewswire) VANCOUVER September 12, 2025 TheNewswire – Providence Gold Mines Inc. (‘Providence’ or the ‘Company’) is pleased to announce a...
Cardiol Therapeutics
Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a...